Jump to content
IndiaDivine.org

Hemoangioma, Hughes syndrome

Rate this topic


Guest guest

Recommended Posts

Namaste Marilette,

 

One of the healers in our group has been diagnosed

with both Hepatic

Hemoangioma and Hughes syndrome. We'd appreciate it a

whole lot if you

could help us with a good healing protocol for her...

 

Thank you very much in advance, and may you always be

blessed!

Jaime Graterol

PH Mexico

 

 

==========================================

 

 

Dear Jaime,

 

Namaste.

 

Thank you for your email.

 

Medical Background:

 

The antiphospholipid antibody syndrome, also known as

Hughes Syndrome, is a disorder characterized by

multiple different antibodies that are associated with

both arterial and venous thrombosis (clots). There are

three primary classes of antibodies associated with

the antiphospholipid antibody syndrome: 1)

anticardiolipin antibodies, 2) the lupus anticoagulant

and 3) antibodies directed against specific molecules

including a molecule known as beta-2-glycoprotein 1.

 

Historically, antiphospholipid antibodies were first

noted in patients who had positive tests for syphilis

without signs of infection. Subsequently, a clotting

disorder was associated with two patients with

systemic lupus erythematosus in 1952. In 1957 a link

between recurrent pregnancy loss and what is now

called the lupus anticoagulant was established.

Ultimately, the lupus anticoagulant was further

described in 1963 and in 1972 the term lupus

anticoagulant was given. In 1983, Dr. Graham Hughes

described the association between antiphospholipid

antibodies and arterial as well as venous thrombosis.

 

There are two main classifications of the

antiphospholipid antibody syndrome. If the patient has

an underlying autoimmune disorder, such as systemic

lupus erythematosus, the patient is said to have

secondary antiphospholipid antibody syndrome. If the

patient has no known underlying autoimmune disorder,

it is termed primary antiphospholipid antibody

syndrome.

 

Mechanism of the Antiphospholipid Antibody Syndrome:

The antiphospholipid antibody syndrome is an

autoimmune phenomenon. The immune system's function is

to watch for and defend against foreign substances in

the human body (for instance, bacteria or viruses).

One component of this defence system is the antibody.

An antibody is a protein that can recognize and bind

to a foreign substance. Once it has bound to this

substance, it can attract other molecules and cells to

destroy the offending molecule.

 

In some disease states, the immune system is not able

to differentiate between foreign invading substances

and normal components of the body; this is referred to

as autoimmunity. There are a number of well known

autoimmune disorders, including systemic lupus

erythematosus, and studies on other diseases have

suggested autoimmune components in a number of other

illnesses.

 

In the antiphospholipid antibody syndrome, the body

produces antibodies that recognize various molecules

in the body that, under normal circumstances, it would

not. These molecules (phospholipids for example) play

a role in the coagulation cascade along with other

functions. The exact mechanism by which the

antiphospholipid antibodies and anticardiolipin

antibodies induce thrombophilic state is not known. A

great deal of research is being done to explore the

interactions these antibodies have with the components

of the coagulation cascade and ultimately their role

in the hypercoaguable state. At this time, there are

numerous theories as to how these antibodies cause a

hypercoaguable state; each of these theories has

supporting evidence and evidence that calls it into

question. For reference, a depiction of the clotting

process is below.

 

Epidemiology of the Antiphospholipid Antibody

Syndrome:

The prevalence in the general population is around

2-4%.

 

Of patients with the antiphospholipid antibody

syndrome, over half (50%) of them have the primary

antiphospholipid antibody syndrome.

 

In persons with systemic lupus erythematosus, around

30% will develop the antiphospholipid antibody

syndrome.

 

In general, anticardiolipin antibodies are more common

that the lupus anticoagulant; anticardiolipin

antibodies occurs approximately 5 times more often

than the lupus anticoagulant in patients with the

antiphospholipid antibody syndrome.

 

In patients with an initial presentation of primary

antiphospholipid antibody syndrome, around 10% will

eventually go on to be diagnosed with an autoimmune

disorder such as systemic lupus erythematosus or a

mixed connective tissue disorder.

 

Risks of the Antiphospholipid Antibody Syndrome:

The role of the antiphospholipid antibody syndrome in

both arterial and venous thrombotic disorders is an

active area of clinical research. To date, studies

examining the role of the antiphospholipid antibody

syndrome in thrombosis are numerous. Clearly, the

antiphospholipid antibody syndrome is associated with

both arterial and venous thrombosis. However, a review

of the literature clearly demonstrates continued

controversy regarding the degree of risk these

antibodies confer. Studies have not shown any clear

differences between patients with the primary

antiphospholipid antibody syndrome versus the

secondary antiphospholipid antibody syndrome.

 

A risk of recurrent thrombi, both arterial and venous,

is associated with the antiphospholipid antibody

syndrome as well. Most studies suggest that patients

who have a recurrent episode will have it in a similar

blood vessel type. In other words, patients who have a

stroke initially will most often have a stroke if they

have a recurrence. None-the-less, patients are

reported that have multiple different types of

thrombotic events.

 

The antiphospholipid antibody syndrome is also

associated with miscarriages as well as other

complications of pregnancy including preterm labor and

preeclampsia. An association with thrombocytopenia

(low platelets) has also been established. This occurs

in 20-40% of patients with the antiphospholipid

antibody syndrome.

 

Treatment of the Antiphospholipid Antibody Syndrome:

Studies of the optimal treatment for the

antiphospholipid antibody syndrome are currently under

way. Treatment of the initial thrombosis in patients

with the antiphospholipid antibody syndrome does not

generally differ from treatment of patients with the

same disorder who do not have the antiphospholipid

antibody syndrome. Anticoagulation with heparin and

then subsequently with oral anticoagulation is

initiated. The duration of anticaogulation in patients

without the antiphospholipid antibody syndrome is

generally 3-6 months. In patients with the

antiphospholipid antibody syndrome, the risk of

recurrence is relatively high for both arterial and

venous thrombotic events. As a result, patients are

generally started on long-term (in some cases

life-long) oral anticoagulation.

 

The treatment of women who are pregnant and have the

antiphospholipid antibody syndrome can result in a

much higher success rate for the pregnancy. Several

regimens have been studied including heparin.

 

The role of medications generally used in autoimmune

disorders to try and control the immune system is

extremely limited. The primary role of these

medications is in patients who have secondary

antiphospholipid antibody syndrome, and they generally

have no effect on the antiphospholipid antibody

syndrome, but can help control the systemic lupus

erythematosus, for example. Anti-platelet drugs, such

as aspirin, are also used. At this time, a large study

looking at the use of aspirin versus oral

anticoagulation is underway in patients with the

antiphospholipid antibody syndrome and stroke. Use of

low-molecular-weight heparins instead of warfarin or

in combination with other medications is also

sometimes used.

 

In the case of patients who are discovered to have the

antiphospholipid antibodies without any known

thrombotic problems, the question of preventative

(prophylactic) treatment is unresolved. Currently,

aspirin is the general recommendation.

 

The use of long-term anticoagulation has risks

associated with it (approximately a 3% chance per year

of having a major hemorrhage, of which approximately

1/5 are fatal). Beginning long-term anticoagulation is

influenced by the patient's overall risk of recurrent

thrombosis balanced against the risks associated with

long-term anticoagulation on an individual basis.

 

Pregnancy and the Antiphospholipid Antibody Syndrome:

As mentioned above, the antiphospholipid antibody

syndrome is associated with complications in

pregnancy. These complications can include

miscarriages, preterm labor, low birth-weight and

preeclampsia.

 

A hemangioma is a benign tumor consisting of a mass of

blood or lymphatic vessels; some appear as birthmarks.

 

 

Source - University of Illinois - Urbana/Champaign

Carle Cancer Center, Hematology Resource Page

 

 

Pranic Healing:

 

1. Invoke and scan before, during and after

treatment.

 

2. Instruct the patient to do 12 cycles of Pranic

Breathing before start of treatment, then to continue

Pranic Breathing during treatment.

 

3. After the patient has completed 12 cycles of

Pranic Breathing, apply general sweeping several times

using LWG.

 

4. Localized thorough sweeping and energizing on the

ajna chakra with EV.

 

5. Localized thorough sweeping on the front, sides

and back of the lungs. Energize through the back of

the lungs with LWG, LWO then LWR.

 

6. Localized thorough sweeping on the basic chakra

alternately with LWG and LWO. Energize the basic

chakra with LWR.

 

7. Localized thorough sweeping on the arms and legs

and their minor chakras alternately with LWG and LWO.

Energize the minor chakras of the arms and legs with

LWR.

 

8. Localized thorough sweeping on the affected parts

alternately with LWG and LWO.

 

Energize the affected part with LB for localizing

effect. Energize the affected part with LWG then

LWO.

 

If the affected part is on the head, near the heart or

spleen, just cleanse and energize the affected part

with EV.

 

9. Localized thorough sweeping on the front and back

heart chakra. Energize through the back heart chakra

with LWG then more of ordinary LWV.

 

10. Localized thorough sweeping on the front and back

solar plexus chakra. Energize with LWG then with more

of ordinary LWV.

 

For experienced advanced Pranic Healers, apply

localized thorough sweeping on the front and back

solar plexus chakra and on th eliver alternately with

LWG and LWO. Energize the solar plexus chakra with

LWB, LWG then LWO.

 

11. Localized thorough sweeping on the front and back

spleen chakra with LWG. Energize the spleen chakra

with LWG then with ordinary LWV. This has to be done

with caution.

 

12. Localized thorough sweeping on the kidneys

alternately with LWG and LWO. Energize the kidneys

with LWR.

 

13. Localized thorough sweeping on the meng mein

chakra.

 

14. Localized thorough sweeping on the throat chakra

alternately with LWG and ordinary LWV. Energize with

LWG then with more of ordinary LWV.

 

15. Stabilize and release projected pranic energy.

 

16. Play the Meditation on Twin Hearts CD. Instruct

the patient to follow the guided meditation.

 

17. Repeat entire treatment 3 times per week.

 

 

For the patient:

 

18. Practice forgiveness, loving kindness and mercy

towards yourself and towards others.

 

19. Practice the Meditation on Twin Hearts properly

everyday, including the physical exercises before and

after the meditation.

 

20. Bathe in water with salt daily before meditation

and before Pranic Healing treatment.

 

Love,

 

Marilette

 

Source materials for all MCKS Pranic Healing protocols are exclusively from the

following books by Master Choa Kok Sui:

Miracles Through Pranic Healing, Advanced Pranic Healing, Pranic Psychtherapy

and pranic Crystal Healing.

 

NOTICE:

1. Pranic Healing is not intended to replace orthodox medicine, but rather to

complement it. If symptoms persist or if the ailment is severe, please consult

immediately a medical doctor and a Certified Pranic Healer.

 

2. Pranic Healers who are are not medical doctors should not prescribe nor

interfere with prescribed medications and/or medical treatments. ~ Master Choa

Kok Sui

 

Miracles do not happen in contradiction to nature, but only to that which is

known to us in nature. ~ St. Augustine

 

Ask or read the up to date Pranic Healing protocols by joining the group

through http://health./

 

MCKS Pranic Healing gateway website: http://www.pranichealing.org.

 

 

 

 

 

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...